Boostertx
Founded 2020 · 11 employees on LinkedIn · 3 known investors
Booster Therapeutics develops small-molecule medicines that directly activate the cell's 20S proteasome to restore protein quality-control and clear disease-causing proteins, using its structure-based DGRADX platform combining high-throughput screening, X-ray crystallography, and computational tools. The company is building a multi-disease pipeline initially focused on neurodegenerative diseases.
Founders & leadership
Boostertx was founded in 2020 by Diogo R. Feleciano and Darci J. Trader.
DR
Diogo R. FelecianoCo-Founder & CSO
DJ
Darci J. TraderScientific Co-Founder / Advisor
JR
João RibasInterim-CBO
Investors · 3
Frequently asked questions
- What does Boostertx do?
- Booster Therapeutics develops small-molecule medicines that directly activate the cell's 20S proteasome to restore protein quality-control and clear disease-causing proteins, using its structure-based DGRADX platform combining high-throughput screening, X-ray crystallography, and computational tools. The company is building a multi-disease pipeline initially focused on neurodegenerative diseases.
- Who founded Boostertx?
- Boostertx was founded by Diogo R. Feleciano, Darci J. Trader in 2020.
- Who are Boostertx's investors?
- Boostertx's investors include Apollo Health Ventures, Novo Holdings, Korify Capital.